DK189584A - (5alfa)-20-spirox-1-en-3-oner samt deres fremstilling og anvendelse - Google Patents
(5alfa)-20-spirox-1-en-3-oner samt deres fremstilling og anvendelse Download PDFInfo
- Publication number
- DK189584A DK189584A DK189584A DK189584A DK189584A DK 189584 A DK189584 A DK 189584A DK 189584 A DK189584 A DK 189584A DK 189584 A DK189584 A DK 189584A DK 189584 A DK189584 A DK 189584A
- Authority
- DK
- Denmark
- Prior art keywords
- 5alfa
- spirox
- oner
- preparation
- potassium
- Prior art date
Links
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 239000003286 potassium sparing diuretic agent Substances 0.000 description 1
- 229940097241 potassium-sparing diuretic Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
- C07J71/0015—Oxiranes at position 9(11)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/001—Lactones
- C07J21/003—Lactones at position 17
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Description
eller monocyclisk arylsulfonyl, eller R^ og' R^ sammen danner en alkylengruppe, som eventuelt er afbrudt med et hetero-atom, fremstilles på kendt måde.
Forbindelserne (I) og (II) har aldosteron-antagoniserende virkning og kan anvendes som kaliumbesparende diuretika.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH197983 | 1983-04-13 | ||
| CH197983 | 1983-04-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK189584D0 DK189584D0 (da) | 1984-04-12 |
| DK189584A true DK189584A (da) | 1984-10-14 |
Family
ID=4223075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK189584A DK189584A (da) | 1983-04-13 | 1984-04-12 | (5alfa)-20-spirox-1-en-3-oner samt deres fremstilling og anvendelse |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4552871A (da) |
| EP (1) | EP0122882A1 (da) |
| JP (1) | JPS59205400A (da) |
| AU (1) | AU2685284A (da) |
| DK (1) | DK189584A (da) |
| ES (1) | ES8602845A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6372712B1 (en) | 1998-05-22 | 2002-04-16 | The Board Of Trustees Of The Leland Stanford Jr. University | Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand |
| WO2003049745A1 (en) | 2001-12-12 | 2003-06-19 | Pharmacia Corporation | Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists |
| EP2671508B1 (en) | 2005-04-28 | 2020-09-16 | Proteus Digital Health, Inc. | Pharma-informatics system |
| US9062126B2 (en) | 2005-09-16 | 2015-06-23 | Raptor Pharmaceuticals Inc. | Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof |
| ES2919563T3 (es) | 2009-02-20 | 2022-07-27 | Enhanx Biopharm Inc | Sistema de administración de medicamentos a base de glutatión |
| KR20180114970A (ko) | 2009-05-06 | 2018-10-19 | 라보라토리 스킨 케어, 인크. | 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3095412A (en) * | 1961-12-19 | 1963-06-25 | Searle & Co | 9alpha, 11alpha-epoxy and 11beta-chloro-9alpha-hydroxy 17alpha-(2-carboxyethyl)-17beta-hydroxyandrost-4-en-3-one gamma-lactones and delta1 and delta6 analogs |
| GB1368731A (en) * | 1972-01-24 | 1974-10-02 | Searle & Co | 9alpha 11alpha-epoxy spirolactones and corresponding spirolactols and lactol ethers |
| IE44711B1 (en) * | 1976-03-05 | 1982-03-10 | Schering Ag | 17 -hydroxypropyl-4-3-keto-steroids and esters thereof, and process for their manufacture |
| US4079054A (en) * | 1976-12-22 | 1978-03-14 | Schering Corporation | 7α-Halogeno-3-oxo-1,4-pregnadiene-21,17β-carbolactones and related compounds |
-
1984
- 1984-04-09 US US06/598,132 patent/US4552871A/en not_active Expired - Fee Related
- 1984-04-10 EP EP84810178A patent/EP0122882A1/de not_active Withdrawn
- 1984-04-11 ES ES531516A patent/ES8602845A1/es not_active Expired
- 1984-04-12 JP JP59071899A patent/JPS59205400A/ja active Pending
- 1984-04-12 DK DK189584A patent/DK189584A/da not_active Application Discontinuation
- 1984-04-12 AU AU26852/84A patent/AU2685284A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59205400A (ja) | 1984-11-20 |
| EP0122882A1 (de) | 1984-10-24 |
| ES531516A0 (es) | 1985-12-01 |
| US4552871A (en) | 1985-11-12 |
| ES8602845A1 (es) | 1985-12-01 |
| AU2685284A (en) | 1984-10-18 |
| DK189584D0 (da) | 1984-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK156062C (da) | 2-imino-3,4-dihydro-5,6-dichlor-quinazolin-3-acetater eller syreadditionssalte deraf samt fremgangsmaade til deres fremstilling | |
| DK490482A (da) | Derivater af cis,endo-2-azabicyclo-(3.3.0)-octan-3-carboxylsyren, fremgangsmaade til deres fremstilling, midler med indhold deraf samt deres anvendelse | |
| DK584284D0 (da) | 3-aminopyrazolo(3,4-d)pyrimidinderivater | |
| DK536381A (da) | 8-arylalkyl-3-phenyl-3-nortropanoler eller syreadditionssalte deraf fremgangsmaade til deres fremstilling samt deres anvendelse | |
| DK153477C (da) | Analogifremgangsmaade til fremstilling af 1-substituerede 4-(diarylmethyl)piperazin- eller 1-substituerede 4-(diarylmethoxy)piperidinderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| IE40570L (en) | Benzylamine derivatives | |
| DK448784D0 (da) | Pyridoindoler, eller syreadditionssalte deraf, deres fremstilling ogmellemprodukter hertil samt deres anvendelse | |
| DK298984A (da) | Tetrahydropyridazinoner eller syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter og disses fremstilling | |
| DK323981A (da) | 4,5-diaryl-alfa-polyfluoralkyl-1h-imidazol-2-methanaminer eller syreadditionssalte deraf deres fremstilling og anvendelse som antiinflammatoriske midler | |
| DK319884A (da) | Fremgangsmaader til fremstilling af 9a-ethyl- og 9a-n-propylderivater af 9-deoxo-9a-aza-9a-homoerythromycin a eller syreadditionssalte deraf | |
| DK150597C (da) | Analogifremgangsmaade til fremstilling af 3,4-bis-substituerede 1,2,5-oxadiazol-2-oxider eller farmakologisk acceptable syreadditionssalte deraf | |
| DK162882A (da) | Imidazolderivater eller syreadditionssalte deraf,deres fremstilling og anvendelse | |
| FI831914A7 (fi) | Pyrimidinonien ja niiden happoadditiosuolojen valmistusmenetelmät. | |
| DK254983D0 (da) | 4-aryl-2-methyl-1,2,3,4-tetrahydroisoquinolinderivater eller syreadditionssalte deraf og fremgangsmade til deres fremstilling | |
| DK161338C (da) | Fremgangsmaade til fremstilling af 2-hydroxyaclacinomycin a, b og n eller syreadditionssalte deraf samt en rekombinant mikroorganisme til anvendelse derved | |
| DK516480A (da) | Fremgangsmaade til fremstilling af 2-amino-ethanol-derivater eller syreadditionssalte deraf | |
| DK150158C (da) | Analogifremgangsmaade til fremstilling af 4-phenylthieno-(2,3-c)piperidiner eller fysiologisk acceptable syreadditionssalte deraf | |
| JPS5331674A (en) | 5-fluorouracil derivatives and their preparation | |
| DK288779A (da) | 2-phenylamino-imidazoliner-(2) eller syreaddiitonssalte deraf fremgangsmaade til deres fremstilling samt deres anvendelse | |
| DK283783D0 (da) | Polyprenylforbindelser, fremgangsmade til deres fremstilling samt deres anvendelse | |
| DK268487A (da) | Alkoxyalkyl- og alkylmercaptoalkylsubstituerede, bicycliske benzofuroisoquinoliner eller syreadditionssalte deraf og deres anvendelse | |
| JPS5318562A (en) | Oxyindole derivatives | |
| DK325178A (da) | Substituerede 1-piperazinyl-triazolo-thieno-1,4-diazepiner eller syreadditionssalte deraf samt fremgangsmaade til deres fremstilling | |
| DK92582A (da) | Alkylendiaminderivater n-oxider eller syreadditionssalte deraf deres fremstilling og anvendelse som antiarytmiske laegemidler | |
| DK296879A (da) | Substituerede 2-phenylamino-imidazoliner-(2) eller syreadditionssalte deraf fremgangsmaade til deres fremstilling samt deres anvendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment | ||
| AHS | Application shelved for other reasons than non-payment |